TTT 3002
TTT 3002 is a potent and orally bioavailable FLT3 inhibitor with an IC50 of 0.2 nM against D835 activation loop mutations. It is a valuable research tool for investigating FLT3-driven acute myeloid leukemia (AML) in both cellular assays and in vivo models.
Product Specifications
CAS Number
871037-95-5
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
C[C@]12N3C=4C5=C (C6=C (C4C=7C3=CC=CC7) CNC6=O) C=8C (N5[C@] (O1) (C[C@@]2 (C (NC) =O) N) [H]) =CC=CC8
Molecular Formula
C27H23N5O3
Molecular Weight
465.50
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
JOT-AP10413-01 20 µL
Histone H2A.Z (Acetyl Lys14) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details JOT-AP10413-02 50 μL
Histone H2A.Z (Acetyl Lys14) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details JOT-AP10413-03 100 µL
Histone H2A.Z (Acetyl Lys14) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details GTR15373182 1 Vial
Lentiviral human BFSP1 sgRNA gene knockout kit - Lentiviral human BFSP1 sgRNA gene knockout kit (25)
Sign In for Pricing
View Details 